Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE2775.102.3 (+0.08 %)

PREV CLOSE ( ) 2772.80

OPEN PRICE ( ) 2700.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6557

TODAY'S LOW / HIGH ( )2700.75 2870.00

52 WK LOW / HIGH ( )2210 3645

NSE2774.40-0.9 (-0.03 %)

PREV CLOSE( ) 2775.30

OPEN PRICE ( ) 2739.00

BID PRICE (QTY) 2774.40 (23)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 167345

TODAY'S LOW / HIGH( ) 2708.00 2875.00

52 WK LOW / HIGH ( )2201.2 3653.95

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

6026

5967

6602

6019

Total Expenditure

4336

4427

4577

4319

PBIDT (Excl OI)

1690

1540

2025

1700

Other Income

258

251

219

206

Operating Profit

1948

1791

2244

1906

Interest

Exceptional Items

PBDT

1898

1738

2184

1846

Depreciation

364

355

353

347

Profit Before Tax

1534

1383

1831

1499

Tax

-21

402

523

421

Provisions and contingencies

Profit After Tax

1555

981

1308

1078

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1555

981

1308

1078

Minority Interest

-7

-14

-16

-14

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1548

967

1292

1064

Equity Capital

836

835

Face Value (IN RS)

Reserves

Calculated EPS

18.51

11.56

15.45

12.74

Calculated EPS (Annualised)

74.06

46.26

61.81

50.97

No of Public Share Holdings

38530600

38526600

38513117

37899217

% of Public Share Holdings

46.09

46.08

45.4

PBIDTM% (Excl OI)

28.04

25.80

30.67

28.24

PBIDTM%

32.32

30.01

33.98

31.66

PBDTM%

31.49

29.12

33.08

30.66

PBTM%

25.45

23.17

27.73

24.90

PATM%

25.80

16.44

19.81

17.90

Notes

Risk Disclosures on Derivatives

Quarterly Results

DR. LAL PATHLABS LTD.